News
Orb Health Announces Health System and Center Program to Scale Patient Access and Coordination for COVID-19 Vaccine Delivery
Enterprise Virtual Care accelerates vaccine delivery for health systems and centers who are experiencing an overwhelming number of patient requests…
News
Orb Health and Anelto Partner to Transform Remote Patient Monitoring into Preventative Connected Care Solution
Enterprise Virtual Care for Chronic Care, combined with remote patient monitoring, drives unprecedented patient outcomes while bending the economics of…
News
Orb Health Named as Marquee “Visionary Sponsor” at AllianceChicago and Health Choice Networks Annual Board of Directors Virtual Educational Conference November 4-12
Orb Health headlines the conference as the marquee sponsor, focused on sharing Enterprise Virtual Care knowledge and outcomes to a…
News
Health Choice Network Selects Orb Health as Chronic Care and Patient Support Partner
Enterprise Virtual Care solution and services accelerates unprecedented patient outcomes while bending the economics of healthcare…
Event
Orb Health CEO Bryan Krastins to Speak on the Future of Healthcare at Questrom’s Eighth Annual Health & Life Sciences Conference
Visionary operational executive with 20+ years’ experience in the healthcare, diagnostics, and technology sectors who will discuss how value-based care…
Event
Mass Hospital Assoc Webinar with Orb Health’s Dr. Preet Goraya on Bending the Economics of Chronic Care Management
Dr. Goraya will show how CHCP achieve a 54% reduction in emergency department utilization, lowered overall patient costs by 26%,…
News
Orb Health Names Healthcare Visionary Entrepreneur and Investor Sheila Schweitzer to Board of Directors
Orb Health announced today that Sheila Schweitzer has joined Orb Health's board of directors.
CCM
COVID-19: CDC says Prepare for vaccine distribution as soon as late October
The CDC urged public health officials nationwide to prepare for vaccine distribution as soon as late October or early November,…
COVID-19
COVID-19: Bracing for the second wave
The mRNA-1273 vaccine induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified.
COVID-19
COVID-19: An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
The mRNA-1273 vaccine induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified.
